KR | EN

News

Press Release

Selected for MOHW Infectious Disease Prevention R&D Project

November 20, 2024 2

SML Biopharm has been selected for the MOHW Infectious Disease Prevention R&D Project, receiving total funding of 2.05 billion KRW over 3 years.

Back to List

Related News

2025.09.15

MOU Signed with Cha Vaccine Institute for mRNA Vaccine Co-development
2025.05.10

MOU Signed with Affilogic (France) for Targeted Drug Development
2025.01.15

MOU with Probio (China) for mRNA Development and Production